At a glance
ClinicalIndex Comparison RecordN/ACompleted· 98 enrolled
Drug / intervention
Tricuspid Valve Repair Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Trial to Evaluate Treatment With Abbott Transcatheter Clip Repair System in Patients With Moderate or Greater Tricuspid Regurgitation (TRILUMINATE)
In Brief
A clinical study evaluating Tricuspid Valve Repair System for Tricuspid Valve Insufficiency. Completed, enrolled 98 participants across 20 sites in 6 countries.
Detailed Summary
The primary purpose of this study is to evaluate safety and effectiveness of the Tricuspid Valve Repair System (TVRS) for treating symptomatic moderate or greater tricuspid regurgitation (TR) in patients currently on medical management and who are deemed appropriate for percutaneous transcatheter intervention.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTricuspid Valve Insufficiency
CountriesFrance, Germany, Italy, Spain, Switzerland, United States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedJul 2017
Enrollment StartAug 2017
Primary CompletionNov 2019
Study CompletionMay 2024
TodayJul 2026
First PostedJul 24, 2017
Enrollment StartAug 1, 2017
Primary CompletionNov 14, 2019
Study CompletionMay 30, 2024
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 8.9 years ago
Interventions
Tricuspid Valve Repair Systemdevice
Subjects who received TVRS will be included in this arm. The TVRS is intended for reconstruction of the insufficient tricuspid valve through tissue approximation.